Medivation, Astellas launch trials in prostate, breast cancers

Medivation Inc. and partner Astellas Pharma Inc. started a pair of clinical trials of their cancer-fighting drug enzalutamide — one in prostate cancer, the other in breast cancer — that could expand the use of the capsules...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.